Indivior | Driftsresultat



Operating Profit Lave om Dato
AstraZeneca USD 2.04B 731M 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Glaxosmithkline GBP 702M 513M 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Indivior 94M 226M 2024-09
J&J USD 3.89B 549M 2024-12
Kyowa Hakko Kirin JPY 26.93B 2.53B 2024-09
Merck USD 4.3B 369M 2024-12
Novartis USD 3.4B 193M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Sanofi EUR 3.64B 1.35B 2024-09
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12



Indivior Driftsresultat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.